Related Articles
The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells
Selective anticancer activity of hirsutine against HER2‑positive breast cancer cells by inducing DNA damage
NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells
Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs
Lapatinib inhibits the activation of NF-κB through reducing phosphorylation of IκB-α in breast cancer cells